MedPath

Maintenance therapy with bacillus Calmette-Guérin Connaught stain for non-muscle invasive bladder cancer after transurethral resection: prospective study with low-dose instillation.

Not Applicable
Conditions
on muscle-invasive bladder cancer
Registration Number
JPRN-UMIN000006362
Lead Sponsor
Graguate school of Medicine, Yamaguchi University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

1 Patients who have current or previous upper tract tumor. 2 Patients whose bladder volume is less than 100 ml, which is mesured by uktrasonography. 3 Patients who suffered with urinary frequency (OAB symptom score<=6) 4 Patients who received BCG theraphy previously. 5 Patients who have contraindication of BCG.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Incidence rate of adverse events 2. Rate of Patients who accomplish the protocol of this study
Secondary Outcome Measures
NameTimeMethod
Recurrence- and progression-rate during 2-year after the final instillation
© Copyright 2025. All Rights Reserved by MedPath